Art

J-GLOBAL ID：201002276079315735   Reference number：10A0672403

Phase II study of oxaliplatin plus S-1 as first-line treatment for advanced gastric cancer (G-SOX study)

進行胃癌の第1選択治療としてのオキサリプラチン+S-1の第2相試験(G-SOX試験)

Author (8)： KOIZUMI W. (Kitasato Univ. School of Medicine, Sagamihara) ,  TAKIUCHI H. (Osaka Medical Coll., Takatsuki) ,  YAMADA Y. (National Cancer Center Hospital, Tokyo) ,  BOKU N. (Shizuoka Cancer Center, Sunto-gun) ,  FUSE N. (National Cancer Center Hospital East, Kashiwa) ,  MURO K. (Aichi Cancer Center Hospital, Nagoya) ,  KOMATSU Y. (Hokkaido Univ. Hospital Cancer Center, Sapporo) ,  TSUBURAYA A. (Kanagawa Cancer Center, Yokohama, JPN)
Material： Annals of Oncology  (Ann Oncol)
Volume： 21  Issue： 5  Page： 1001-1005  Publication year： May. 2010 
JST Material Number： W0107A  ISSN： 0923-7534  CODEN： ANONE2  Document type： Article
Article type： 原著論文  Country of issue： United Kingdom (GBR)  Language： ENGLISH (EN)

Thesaurus term： human(primates) ,...
Semi thesaurus term： *oxaliplatin ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=10A0672403&from=J-GLOBAL&jstjournalNo=W0107A") }}

JST classification (2)： Clinical application of antitumor(=antineoplastic)drugs  (GW16020L) ,  Drug therapy(=pharmacotherapy)for tumors  (GE03032C)

Substance index (1)： TS-1

Reference (16)：

• Murad AM, Santiago FF, Petroianu A et al. Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer. Cancer 1993; 72: 37-41.
• Glimelius B, Hoffman K, Haglund U et al. Initial or delayed chemotherapy with best supportive care in advanced gastric cancer. Ann Oncol 1994; 5: 189-190.
• Pyrhönen S, Kuitunen T, Nyandoto P, Kouri M. Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer. Br J Cancer 1995; 71: 587-591.
• Waters JS, Norman A, Cunningham D et al. Long-term survival after epirubicin, cisplatin and fluorouracil for gastric cancer: results of a randomized trial. Br J Cancer 1999; 80: 269-272.
• Van Cutsem E, Moiseyenko VM, Tjulandin S et al. Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as firstline therapy for advanced gastric cancer: a report of the V325 Study Group. J Clin Oncol 2006; 24: 4991-4997.

Terms in the title (6)： 進行胃癌 ,  治療 ,  オキサリプラチン ,  第2相試験 ,  SOx ,  試験